Please see below for a list of search results.
This policy sets out the legal requirements of the HT Act with regard to consent for post-mortem examination, tissue retention and storage of tissue from the deceased.
The Human Tissue Act 2004 requires that the removal of tissue from the deceased for research within the scope of the Act must always be licensed, on specified premises, and that specific minimum requirements are met.
A practical guide to implementing the Human Tissue Act (2004)'s requirements around research
Establishments that conduct human tissue research under recognised research ethics committee approvals are exempt from being licensed for the storage of relevant material for research under the HT Act 2004.
The Human Tissue Authority (HTA), the regulator for human tissue, cells and organs, has today published compliance reports for establishments licensed in the Anatomy and
Schedule 1 of the Human Tissue Act 2004 (the Act) sets out ‘performance assessment’ as a ‘scheduled purpose’.
An HTA licence is required if the human cellular material (‘relevant material’) to be stored for performance assessment has been removed from the deceased.
The following guidance has been produced to bring clarity to the issues surrounding consent for research relating to transplantation where donors are deceased.
These guides set out your basic rights when dealing with an establishment regulated by the HTA.
Last summer, the Health Research Authority (HRA) and the Human Tissue Authority (HTA) - in partnership with the Department for Business, Enterprise, Innovation and Skills’ (BEIS) Sciencewise programme and Ipsos MORI - published the report ‘